PMC:7029759 / 1867-2067
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":87,"end":95},"obj":"Species"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help "}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T3","span":{"begin":21,"end":28},"obj":"BV_20"},{"id":"T2","span":{"begin":29,"end":39},"obj":"BV_20;GO:0010467"},{"id":"T1","span":{"begin":67,"end":71},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"e use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help "}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":21,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"e use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T19","span":{"begin":177,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"e use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":21,"end":28},"obj":"Chemical"},{"id":"T6","span":{"begin":67,"end":71},"obj":"Chemical"},{"id":"T7","span":{"begin":127,"end":133},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_48341"}],"text":"e use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help "}